Bed bug histamines persistent in infested areas

New research suggests bed bugs are a medically important threat


New research suggests bed bugs are a medically important threat, according to an article on the Infection Control Today website.

A North Carolina State University study shows that histamine levels are substantially higher in areas bed-bug-infested areas and that these histamine levels persist for months after the bed bugs have been eliminated.

“Histamine levels in bed bug-infested homes were at least 20 times higher than histamine levels in homes without bed bugs,” the study's author said. “And these levels didn’t decrease much three months after treating the infested homes with heat and insecticides.”

Bed bugs naturally give off high levels of histamine in their feces. They use histamine as a marker of a good place to aggregate. 

Read the article.

 

 



February 16, 2018


Topic Area: Infection Control


Recent Posts

Contaminants Under Foot: A Closer Look at Patient Room Floors

So-called dust bunnies on hospital room floors contain dust particles that turn out to be the major source of the bacteria humans breathe.


Power Outages Largely Driven by Extreme Weather Events

Almost half of power outages in the United States were caused by extreme weather events.


Nemours Children's Health Opens New Moseley Foundation Institute Hospital


Code Compliance Isn't Enough for Healthcare Resilience

Intensifying climate risks are pushing hospitals to think beyond code requirements and toward long-term resilience.


Ribbon Cutting Marks First Phase Completion for New Montefiore Einstein Facility

The second phase is expected to be completed in the second half of 2027.


 
 


FREE Newsletter Signup Form

News & Updates | Webcast Alerts
Building Technologies | & More!

 
 
 


All fields are required. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

 
 
 
 

Healthcare Facilities Today membership includes free email newsletters from our facility-industry brands.

Facebook   Twitter   LinkedIn   Posts

Copyright © 2023 TradePress. All rights reserved.